Anidulafungin

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1395 publications

Correction: Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

Correction: Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

Journal: Frontiers in pharmacology

Published: June 22, 2026

Clinical Outcomes of Micafungin and Anidulafungin in Candidozyma auris (Formerly Candida auris) Candidemia: A Propensity Score-Matched Retrospective Cohort Study.

Clinical Outcomes of Micafungin and Anidulafungin in Candidozyma auris (Formerly Candida auris) Candidemia: A Propensity Score-Matched Retrospective Cohort Study.

Journal: Journal of fungi (Basel, Switzerland)

Published: June 03, 2026

Candidozyma auris susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents.

Candidozyma auris susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents.

Journal: JAC-antimicrobial resistance

Published: May 29, 2026

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of Aspergillus fumigatus to echinocandins with the EUCAST E.Def 9.4.

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of Aspergillus fumigatus to echinocandins with the EUCAST E.Def 9.4.

Journal: Journal of clinical microbiology

Published: May 22, 2026

Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model.

Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model.

Journal: mBio

Published: May 20, 2026

Evaluation of Sensititre YeastOne for antifungal susceptibility testing of Candida (Candidozyma) auris: misclassification of FKS1 mutants and overestimation of caspofungin resistance in a global collection of isolates.

Evaluation of Sensititre YeastOne for antifungal susceptibility testing of Candida (Candidozyma) auris: misclassification of FKS1 mutants and overestimation of caspofungin resistance in a global collection of isolates.

Journal: Journal of clinical microbiology

Published: May 14, 2026

Predictors of Candida auris Infection in Previously Colonized Patients: A Retrospective Cohort Study from a Large Tertiary Reference Center.

Predictors of Candida auris Infection in Previously Colonized Patients: A Retrospective Cohort Study from a Large Tertiary Reference Center.

Journal: Journal of fungi (Basel, Switzerland)

Published: May 08, 2026

Therapeutic Challenges in Case of Trichophyton indotineae Dermatophytosis, Singapore, 2025.

Therapeutic Challenges in Case of Trichophyton indotineae Dermatophytosis, Singapore, 2025.

Journal: Emerging infectious diseases

Published: May 01, 2026

Comparative Analysis of Virulence Traits and Fluconazole-Response Mechanisms in Clinical Isolates of Candidozyma auris.

Comparative Analysis of Virulence Traits and Fluconazole-Response Mechanisms in Clinical Isolates of Candidozyma auris.

Journal: Microorganisms

Published: April 30, 2026

Identification and characterization of anti-chikungunya virus compounds using a biosafe toolkit.

Identification and characterization of anti-chikungunya virus compounds using a biosafe toolkit.

Journal: Virologica Sinica

Published: April 30, 2026

In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.

In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.

Journal: Journal of fungi (Basel, Switzerland)

Published: April 28, 2026

Rasamsonia argillacea in Patient with Immunodeficiency: First Suspected Case in Türkiye

Rasamsonia argillacea in Patient with Immunodeficiency: First Suspected Case in Türkiye

Journal: Mikrobiyoloji bulteni

Published: April 27, 2026

Showing 1-12 of 1,395

Last Updated: 09/26/2026